BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:OP-3136 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of OP-3136\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06784193-2658@assetmemo.bio
DTSTAMP:20261121T005814Z
DTSTART;VALUE=DATE:20270530
DTEND;VALUE=DATE:20270531
SUMMARY:OP-3136: Phase 1 readout est. (NCT06784193)
DESCRIPTION:OP-3136\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Phase 1
  Study of OP-3136 in Advanced or Metastatic Solid Tumors\nEstimated primar
 y completion: 30 May 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/op-3136#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT06784193
URL:https://assetmemo.bio/drug/op-3136#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
